Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.
News
Ocular Toxicity Rare in Patients Taking Hydroxychloroquine
- Author:
- Sharon Worcester
News
Lupus Patient Subgroups Benefit From Rituximab
- Author:
- Sharon Worcester
News
Patient Subgroup Response to Belimumab Remains Unclear
- Author:
- Sharon Worcester
News
Bosentan May Reduce Skin Fibrosis in Scleroderma
- Author:
- Sharon Worcester
News
Data Don't Support High-Dose Vitamin D Intake
- Author:
- Sharon Worcester
News
Obesity May Eliminate Need for DXA Osteoporosis Screening
- Author:
- Sharon Worcester
Major Findings: Hip osteoporosis was seen in 2.7% of obese patients, and lumbar spine osteoporosis was observed in 7.2%, compared with 10.7% and...
News
Obesity May Eliminate Need for DXA Osteoporosis Screening
- Author:
- Sharon Worcester
Major Findings: Hip osteoporosis was seen in 2.7% of obese patients, and lumbar spine osteoporosis was observed in 7.2%, compared with 10.7% and...
News
3e Initiative Proposes IA Pain Management Recommendations
- Author:
- Sharon Worcester
News
3e Initiative Proposes IA Pain Management Recommendations
- Author:
- Sharon Worcester
News
Family Study Reveals Possible RA Risk Factors
- Author:
- Sharon Worcester
Major Finding: For patients with RA and their first-degree relatives, compared to healthy controls, median concentrations of the anti-CCP...
News
Family Study Reveals Possible RA Risk Factors
- Author:
- Sharon Worcester
Major Finding: For patients with RA and their first-degree relatives, compared to healthy controls, median concentrations of the anti-CCP...
News
Tofacitinib Effective for RA in Phase III Study
- Author:
- Sharon Worcester
Major Findings: In the 5-mg, 10-mg, and placebo groups, respectively, ACR 20 responses at 6 months were 52.7%, 58.3%, and 31.2%; DAS28-4(ESR)...
News
Tofacitinib Effective for RA in Phase III Study
- Author:
- Sharon Worcester
Major Findings: In the 5-mg, 10-mg, and placebo groups, respectively, ACR 20 responses at 6 months were 52.7%, 58.3%, and 31.2%; DAS28-4(ESR)...
News
Aspirin, Methotrexate Are Adjunctive Therapy Options in GCA
- Author:
- Sharon Worcester
News
Aspirin, Methotrexate Are Adjunctive Therapy Options in GCA
- Author:
- Sharon Worcester